Snyder Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.4M Buy
102,432
+4,771
+5% +$2.29M 0.89% 46
2026
Q1
$48M Sell
97,661
-15,201
-13% -$8.25M 0.93% 44
2025
Q4
$65.4M Buy
112,862
+14,577
+15% +$8.24M 1.22% 32
2025
Q3
$47.7M Buy
98,285
+40,997
+72% +$19.1M 0.9% 44
2025
Q2
$23.2M Buy
57,288
+10,935
+24% +$4.57M 0.49% 58
2025
Q1
$23.1M Buy
46,353
+135
+0.3% +$73.1K 0.5% 60
2024
Q4
$24M Sell
46,218
-957
-2% -$526K 0.5% 59
2024
Q3
$29.2M Buy
47,175
+9,295
+25% +$5.5M 0.61% 56
2024
Q2
$20.9M Buy
+37,880
New +$21.7M 0.47% 60

Other funds holding TMO

Snyder Capital Management's TMO Position: Q2 2026 in Review

Snyder Capital Management increased its Thermo Fisher Scientific (TMO) stake by 4.9% in Q2 2026, buying an estimated $2.29M and bringing the position to 102,432 shares worth $51.4M. The position accounts for 0.89% of the portfolio, ranked #46.

Snyder Capital Management first reported a position in TMO in Q2 2024 and has held it in 9 quarters since. The position peaked at $65.4M in Q4 2025. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Snyder Capital Management held 102,432 shares of Thermo Fisher Scientific worth $51.4M as of Q2 2026.
  • Snyder Capital Management bought 4,771 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.29M.
  • Thermo Fisher Scientific made up 0.89% of Snyder Capital Management's portfolio in Q2 2026, its #46 holding.
  • Snyder Capital Management first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 9 quarters since.
  • Snyder Capital Management's Thermo Fisher Scientific position peaked at $65.4M in Q4 2025.
  • 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Snyder Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.